# PET Scan in Patients With Lung and Esophageal Cancers That May Be Removed by Surgery

> **NCT00002930** · PHASE2,PHASE3 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 75 (estimated)

## Conditions studied

- Esophageal Cancer
- Lung Cancer

## Interventions

- **PROCEDURE:** positron emission tomography
- **RADIATION:** fludeoxyglucose F 18

## Key facts

- **NCT ID:** NCT00002930
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-12
- **Primary completion:** 2002-10
- **Final completion:** —
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2013-01-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002930

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002930, "PET Scan in Patients With Lung and Esophageal Cancers That May Be Removed by Surgery". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00002930. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*